Valuation: Diaceutics PLC

Market Cap 171M 229M 204M 189M 322M 21.63B 326M 2.27B 888M 11.36B 858M 841M 36.22B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 163M 219M 195M 180M 307M 20.65B 311M 2.16B 848M 10.85B 820M 803M 34.59B EV / Sales 2026 *
3.5x
EV / Sales 2027 * 2.85x
Free-Float
72%
Yield 2026 *
-
Yield 2027 * -
1 day-1.47%
1 week-0.49%
Current month+5.22%
1 month+18.53%
3 months+52.08%
6 months+22.87%
Current year+57.42%
1 week 200
Extreme 200
210
1 month 170
Extreme 170
210
Current year 125
Extreme 125
210
1 year 125
Extreme 125
210
3 years 82
Extreme 82
210
5 years 74
Extreme 74
210
10 years 74
Extreme 74
210
Manager TitleAgeSince
Chief Executive Officer 42 2023-12-31
Director of Finance/CFO - 2022-03-17
Chief Operating Officer - -
Director TitleAgeSince
Chairman 65 2024-09-30
Director/Board Member 42 -
Director/Board Member 42 2024-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
5/5/26 Buy

Chief Financial Officer

90 0.0001%
5/5/26 Free

Chief Financial Officer

90 0.0001%
5/5/26 Free

Executive/Senior Manager

89 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.47%-0.49%+24.77%+119.02% 232M
+0.31%+2.98%+18.42%+74.76% 746B
+1.44%+6.67%+14.46%+76.76% 86.18B
+2.41%+0.79%+6.87%+163.04% 64.97B
+0.11%+1.83%-17.34%+7.14% 48.88B
+0.14%+1.76%+2.24%+77.83% 47.21B
+0.07%-17.06%+57.40%+805.86% 46.99B
+1.95%+1.51%+9.03%+36.66% 31.55B
-0.20%+2.12%+42.48%+70.53% 26.81B
-0.08%+3.32%-61.16%-56.37% 25.66B
Average +0.20%-0.13%+9.72%+137.52% 112.48B
Weighted average by Cap. +0.32%+1.61%+15.34%+103.60%

Financials

2026 *2027 *
Net sales 46.72M 62.56M 55.68M 51.57M 87.87M 5.91B 89.08M 619M 243M 3.1B 234M 230M 9.89B 56.34M 75.44M 67.15M 62.2M 106M 7.12B 107M 746M 293M 3.74B 283M 277M 11.93B
Net income -1.1M -1.47M -1.31M -1.21M -2.07M -139M -2.1M -14.57M -5.71M -73.07M -5.52M -5.41M -233M 2.85M 3.82M 3.4M 3.15M 5.36M 360M 5.43M 37.75M 14.8M 189M 14.3M 14.01M 604M
Net Debt -7.73M -10.35M -9.21M -8.53M -14.54M -977M -14.74M -102M -40.14M -513M -38.79M -38.01M -1.64B -10.4M -13.92M -12.39M -11.48M -19.55M -1.31B -19.82M -138M -53.98M -691M -52.17M -51.12M -2.2B
Projected Income Statement - Annual - Diaceutics PLC
Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205
Date Price Change Volume
26-10-21 GBX 201.50 -1.47% 305,114
26-10-20 GBX 204.50 0.00% 49,913
26-10-19 GBX 204.50 +0.49% 167,477
26-10-16 GBX 203.50 +0.49% 575,986
26-10-15 GBX 202.50 0.00% 210,066
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Diaceutics PLC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.015GBP
Average target price
2.130GBP
Spread / Average Target
+5.71%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Diaceutics PLC
  1. Stock Market
  2. Stocks
  3. DXRX Stock